Yu-Jun Dong
Overview
Explore the profile of Yu-Jun Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng H, Li S, Liang Z, Feng R, Lu J, Dong Y, et al.
Medicine (Baltimore)
. 2025 Feb;
104(9):e41683.
PMID: 40020100
Due to the severe consequences of viral infection in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients, the routine use of polymerase chain reaction (PCR) screening of viruses is common in...
2.
Zhao S, Liu H, Yang X, Xie W, Xue C, He X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2025 Feb;
33(1):127-132.
PMID: 40017196
Objective: To screen novel diagnostic marker or therapeutic target for multiple myeloma (MM). Methods: and were identified by bioinformatics method based on GEO database as high expression genes in MM....
3.
Cai Z, Xia Z, He A, Dong Y, Wang Y, Liao A, et al.
Cancer
. 2024 Dec;
131(1):e35665.
PMID: 39660861
Introduction: Teclistamab, the first approved B-cell maturation antigen-directed bispecific antibody for treatment of triple-class exposed relapsed/refractory multiple myeloma, demonstrated deep, durable responses with a manageable safety profile in the pivotal...
4.
Zhou J, Chen Y, Yuan H, Xu Y, Huang X, Gao S, et al.
Bone Marrow Transplant
. 2024 Nov;
60(3):310-318.
PMID: 39587323
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, allo-HSCT is not appropriate for all...
5.
Zhang L, Liu Q, Zhou H, Zhang H, Dong Y, Wang X, et al.
Blood Adv
. 2024 Sep;
8(21):5598-5602.
PMID: 39293084
According to the diagnostic criteria for human herpesvirus 8 (HHV-8)-negative/idiopathic multicentric Castleman disease (iMCD) proposed by Castleman Disease Collaborative Network in 2017, there is a group of HHV-8-negative patients with...
6.
Yu J, Liang Z, Fu Y, Peng X, Zheng Y, Dong Y, et al.
Virol Sin
. 2024 Jun;
39(4):705-707.
PMID: 38914259
No abstract available.
7.
Xu Z, Xu L, Zhang Y, Zhou Y, Jiang E, Zhang J, et al.
Haematologica
. 2024 Feb;
109(6):2000-2004.
PMID: 38299673
No abstract available.
8.
Jian Y, Chang L, Shi M, Sun Y, Chu X, Xue H, et al.
Blood Adv
. 2023 Nov;
7(24):7581-7584.
PMID: 37922425
No abstract available.
9.
Zhou J, Wang S, Yuan H, Xu Y, Huang X, Gao S, et al.
Am J Hematol
. 2023 Jun;
98(9):1394-1406.
PMID: 37366294
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curable treatment. The outcomes after transplant are influenced by...
10.
Zhang L, Dong Y, Peng H, Li H, Zhang M, Wang H, et al.
Lancet Reg Health West Pac
. 2023 Jun;
34:100720.
PMID: 37283978
Background: Castleman disease (CD) is a group of rare and heterogenous lymphoproliferative disorders including unicentric CD (UCD), human herpesvirus-8(HHV-8)-associated multicentric CD (HHV8-MCD), and HHV-8-negative/idiopathic multicentric CD (iMCD). Knowledge of CD...